Plus: Are multivitamins totally worthless? | Thursday, October 23, 2025
 
Axios View in browser
 
Presented By Goldman Sachs 10,000 Small Businesses
 
Axios Northwest Arkansas
By Ashley May · Oct 23, 2025

Good morning! Axios' Ashley May here with a special newsletter pulling back the curtain on supplements promising optimal health and longevity.

☀️ Today should be sunny with highs in the mid-70s.

Today's newsletter is 982 words, a 3.5-minute read.

 
 
1 big thing: Not your grandfather's horse pills
 
Illustration of a hand holding a pill, collaged with sparkle shapes.

Illustration: Allie Carl/Axios

 

New supplements aren't just boasting vitamins and minerals; they also promise to be beautiful, delicious and vegan.

Why it matters: People are relying on marketing messages instead of their personal health needs to pick and choose what to take.

Threat level: Most people aren't regularly talking with their primary care physician about supplements, and even if they did, doctors and many health care professionals "have no clue here," Taylor Wallace, CEO of Think Healthy Group and editor of the Journal of Dietary Supplements, tells Axios.

  • "I always suggest consulting with a registered dietitian nutritionist (RDN) about supplement regimens to make sure you aren't getting too much," Wallace says.

What they're saying: Glossy marketing messages can also be a red flag, says Pieter Cohen, associate professor at Harvard Medical.

  • Cohen, who has been researching the supplement industry for decades, says he knows the dangers of supplements and how labels can be wrong about ingredients and amounts.
  • "If the supplement label suggests it will have some immediate or really any health benefit, I recommend not taking it."

"Farm to capsule" — that's what people really believe, "Why Wellness Sells" author Colleen Derkatch said in a recent podcast.

  • "That these are plants that are grown in very kind of bucolic fields with little down-home, families farming, and somehow they kind of magic their way into capsule form.
  • "And the similarities to pharmaceuticals become a lot murkier, right? They are pills and bottles. They are synthesized in labs. There's a lot of correspondence between the two things."

Third-party verification is one way consumers can check to see if the new supplement their TikTok feed is raving about is actually what it says it is.

  • Groups including NSF and USP offer verified product directories.
  • Always tell doctors prescribing you medication what supplements you're taking to make sure they don't react poorly to one another.

The bottom line: No matter what they look like, supplements are processed pills with a business behind them.

Share on Facebook Tweet this Story Post to LinkedIn Post to LinkedIn Email this Story
 
 
2. Supplement sales surge
 
Two line charts showing the change in retail sales of suplements and vitamins in the U.S. for the previous 12 month period from September 2021 to September 2025. Sales of supplements changed from $7.8b to $9b. Vitamin sales changed from $3.6b to $3.3b.
Data: NielsenIQ U.S. xAOC; Note: Tracked sales from brick-and-mortar stores; Chart: Jacque Schrag/Axios

Sales of supplements, which typically contain multiple ingredients, are outselling main-ingredient vitamins (think: vitamin C or D capsules), according to data from NielsenIQ.

Why it matters: Consumers are pouring more money into products promising weight loss, sleep and stress relief — part of a bigger global shift toward spending on wellness.

Zoom out: Globally, 82% of consumers say health product labels need to be more transparent, and a quarter cite lack of trust in effectiveness as a barrier to healthier choices, according to NIQ's Global Health & Wellness Trends report.

Share on Facebook Tweet this Story Post to LinkedIn Post to LinkedIn Email this Story
 
 
3. The politics of vitamin pills
 
Photo illustration of Robert Kennedy Jr. collaged with images of pills.

Robert F. Kennedy Jr. Photo illustration: Allie Carl. Photo: Win McNamee/Getty Images

 

Health and Human Services Secretary Robert F. Kennedy Jr. has been portrayed as supplements' savior, but his FDA plans may not go down easy.

Why it matters: Millions of Americans take supplements, and how the federal government treats them impacts everything from individual health to a booming business' bottom line.

Catch up quick: The FDA regulates supplements (a more than $60 billion industry), but unlike prescription drugs, companies don't need preapproval to sell them. The agency usually only steps in after a product is flagged as unsafe or misleading.

What we're hearing: Kennedy, known for taking multiple vitamins himself and touting some supplements as treatments, is directing the FDA to require review of all Generally Recognized as Safe (GRAS) affirmations — the process companies use to show a substance is safe to eat without needing full agency approval.

Between the lines: That proposal might be "well intentioned," Natural Products Association CEO Daniel Fabricant says, but could drive up supplement prices and limit consumer choice.

  • Fabricant, a former FDA director, says the food and supplement industries could face "one standard federally, and then 50 other standards state-wise. How is that workable for anybody?"

Reality check: Kennedy has a lot going on, from weighing in on childhood vaccinations to pushing for autism cures and fighting food additives.

What they're saying: "We encourage individuals to consult a healthcare provider when choosing a dietary supplement, and we will continue working to strike the right balance between protecting public health and respecting personal choice," HHS spokesperson Andrew Nixon told Axios in an emailed statement.

The bottom line: While Kennedy's nutritional tilt energizes supplement makers, his FDA proposals could still introduce new regulatory hurdles that the industry may not fully welcome.

Share on Facebook Tweet this Story Post to LinkedIn Post to LinkedIn Email this Story
 
 

A message from Goldman Sachs 10,000 Small Businesses

Small businesses are America’s engines of growth
 
 

Small businesses strengthen local communities and economies, making up the majority of U.S. businesses, and Goldman Sachs 10,000 Small Businesses alumni represent over $29.3 billion in revenue and 327,000 jobs.

See how Goldman Sachs is convening small business leaders at the 2025 Summit.

 
 
4. The truth about multivitamins
 
Illustration of a woman holding a bottle of vitamins, surrounded by pill imagery.

Illustration: Maura Kearns/Axios

 

Multivitamins aren't magical substitutes for a healthy lifestyle, but they could be a part of one.

The big picture: A multivitamin feels like an easy health insurance policy, but most health professionals say healthy, whole foods are still the best bet.

Most research on multivitamins shows they're low-risk and low-reward. For older adults, there are some documented benefits.

  • "When we've seen actually quite consistent findings for potential benefits of a multivitamin on cognition, I would say that applies to men over 60 and women over 65," says Howard Sesso, an associate epidemiologist at Brigham and Women's Hospital and Harvard Medical School associate professor of medicine, who has led multivitamin clinical trials.
  • In a study of men 50 and older, daily multivitamin use had a "very modest" reduction in cancer as well as forms of eye disease, Sesso says.

Between the lines: Research on multivitamins, and really everything, has been conducted on more men than women.

  • Avoid products with botanicals and a long list of additives, Sesso says. Those don't always mix well with other medications such as GLP-1s or hypertensive meds.

Fun fact: While Sesso agrees that benefits are minimal, he decided to start taking a multivitamin at age 50 ("once I hit the eligibility criteria for the studies that I've been conducting") even though he eats a healthy diet and stays active.

  • His advice for multivitamin shoppers: Skip the pricier "specialized formulations" and go with a major brand.
Share on Facebook Tweet this Story Post to LinkedIn Post to LinkedIn Email this Story
 
 

A MESSAGE FROM GOLDMAN SACHS 10,000 SMALL BUSINESSES

Small business owners embrace innovation to create jobs
 
 

When Mark Stosich took over his father’s business — Stosich, Inc., the second largest employer in his town — he continued his legacy of innovation, opting to build rather than purchase his own equipment.

See how Goldman Sachs 10,000 Small Businesses is advocating for innovation at the 2025 Summit.

 

Thanks to my editor Shane Savitsky.

HQ
Want to help Axios grow? Become a member.
Support your local newsroom and gain access to exclusive insights from reporters, event invitations and more!
 

Axios thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.
Advertise with us.

Axios, PO Box 101060, Arlington VA 22201
 
You received this email because you signed up for newsletters from Axios.
To stop receiving this newsletter, unsubscribe or manage your email preferences.
 
Was this email forwarded to you?
Sign up now to get Axios in your inbox.
 

Follow Axios on social media:

Axios on Facebook Axios on X Axios on Instagram Axios on LinkedIn